Chronic Myeloproliferative Disorders Completed Phase 1 Trials for Methylprednisolone (DB00959)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004232Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerSupportive Care
NCT00004904Stem Cell Transplantation in Treating Patients With Hematologic CancerTreatment
NCT00054236Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaTreatment